The Effects of Stimulant Medication on the Growth of Hyperkinetic Children
- 1 June 1979
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 63 (6), 847-850
- https://doi.org/10.1542/peds.63.6.847
Abstract
The literature on possible growth-suppressing effects of stimulant medications in the long-term treatment of children with the hyperkinetic behavior syndrome is reviewed. The evidence clearly indicates a temporary retardation in the rate of growth in weight and suggests a temporary slowing of growth in stature, but no effect on adult stature or weight. This temporary effect on growth is present during the first few years of treatment and seems related to drug dosage and to the presence or absence of drug holidays. These conclusions relate specifically to treatment during the prepubertal period; little is known of the growth-related effects of treatment extending through pubescence.This publication has 6 references indexed in Scilit:
- GROWTH AND CARDIOVASCULAR MEASURES IN HYPERACTIVE INDIVIDUALS AS YOUNG-ADULTS AND IN MATCHED NORMAL CONTROLS1978
- The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive childrenThe Journal of Pediatrics, 1977
- Growth of Hyperkinetic Children Taking Methylphenidate, Dextroamphetamine, or Imipramine/DesipraminePediatrics, 1976
- Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.Archives of Disease in Childhood, 1966
- BENZEDRINE® AND DEXEDRINE® IN THE TREATMENT OF CHILDREN'S BEHAVIOR DISORDERSPediatrics, 1950
- Growth charts for use in pediatric practiceThe Journal of Pediatrics, 1945